Mike-Andrew Westhoff

13PUBLICATIONS
20CO-AUTHORS
Molecular targetsNanotoxicology, health and safetyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Electrical energy transmission, networks and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2024
The Potential Role of the Extracellular Matrix Glycoprotein Reelin in Glioblastoma Biology.

Erika Ongemach, Daniela Zerrinius, Philipp Heimann

|Feb 21, 2023
How to Respond to Misinformation From the Anti-Vaccine Movement.

Mike-Andrew Westhoff, Carsten Posovszky, Klaus-Michael Debatin

|Oct 14, 2022
Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma.

Trang T T Nguyen, Enyuan Shang, Mike-Andrew Westhoff

|Apr 13, 2022
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.

Trang T T Nguyen, Enyuan Shang, Salveena Schiffgens

|Jan 21, 2022
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy.

Mike-Andrew Westhoff, Marie Schuler-Ortoli, Daniela Zerrinius

|Aug 27, 2021
Photodynamic Therapy Combined with Bcl-2/Bcl-xL Inhibition Increases the Noxa/Mcl-1 Ratio Independent of Usp9X and Synergistically Enhances Apoptosis in Glioblastoma.

Carolin Golla, Mayas Bilal, Annika Dwucet

Pageof 3

Frequent Collaborators

4 joint publications

Trang T T Nguyen

3 joint publications

Georg Karpel-Massler

2 joint publications

Dieter Henrik Heiland

2 joint publications

Klaus-Michael Debatin